Get in Touch
ERG’s mission is to provide the highest quality clinical trial execution across all clinical research phases to help sponsors.
ERG supports integrated obesity clinical trials as an end-to-end clinical research partner, from first-in-human studies through Phase 3 registration.
sites with obesity expertise
of obesity studies
overweight and obese subjects
Incretin, Injectables, Biologic, Non-incretin, Oral, Small Molecule
List of Broad IP Experiences Word Count = 7
With many next-generation obesity therapies that target metabolic pathways influencing central nervous system function, sponsors increasingly require expertise that extends beyond traditional metabolic endpoints. ERG's interdisciplinary network brings together specialists in obesity, psychiatry, neurology, addiction, and sleep medicine to support comprehensive evaluation of metabolic, cognitive, and behavioral outcomes. This multidisciplinary approach enables well-rounded, scientifically rigorous studies that address emerging safety and efficacy considerations.
ERG combines centralized and local recruitment with our proprietary technology-enabled tools and robust participant database of over 260,000 overweight and obese profiles to rapidly identify and connect qualified participants with obesity and metabolic clinical trials. Our continuously expanding overweight and obese participant database grows by approximately 10,000 new overweight and obese profiles each month and includes diverse participants across BMI categories, age groups, and demographics. Our scalable, data-driven approach enables targeted outreach and accelerated enrollment supporting recruitment of participant populations that better reflect real-world obesity demographics.
ERG’s mission is to provide the highest quality clinical trial execution across all clinical research phases to help sponsors.
